1,3,5,6-TetrahydroxyxanthoneCAS# 5084-31-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 5084-31-1 | SDF | Download SDF |
| PubChem ID | 5479774 | Appearance | Yellow powder |
| Formula | C13H8O6 | M.Wt | 260.2 |
| Type of Compound | Xanthones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1,3,5,6-tetrahydroxyxanthen-9-one | ||
| SMILES | C1=CC(=C(C2=C1C(=O)C3=C(C=C(C=C3O2)O)O)O)O | ||
| Standard InChIKey | CCEBJWKUMKKCDF-UHFFFAOYSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. 1,3,5,6-Tetrahydroxyxanthone can inhibit angiotensin-I-converting-enzyme activity in a dose-dependent manner. 2. 1,3,5,6-Tetrahydroxyxanthone shows moderate hepatoprotective activity with EC(50) values of 160.2 +/- 0.6 microM against tacrine-induced cytotoxicity in HepG2 cells. |
1,3,5,6-Tetrahydroxyxanthone Dilution Calculator
1,3,5,6-Tetrahydroxyxanthone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.8432 mL | 19.216 mL | 38.432 mL | 76.864 mL | 96.0799 mL |
| 5 mM | 0.7686 mL | 3.8432 mL | 7.6864 mL | 15.3728 mL | 19.216 mL |
| 10 mM | 0.3843 mL | 1.9216 mL | 3.8432 mL | 7.6864 mL | 9.608 mL |
| 50 mM | 0.0769 mL | 0.3843 mL | 0.7686 mL | 1.5373 mL | 1.9216 mL |
| 100 mM | 0.0384 mL | 0.1922 mL | 0.3843 mL | 0.7686 mL | 0.9608 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 14,15-Didehydroisoeburnamine
Catalog No.:BCN5619
CAS No.:50838-11-4
- Vortioxetine
Catalog No.:BCC2046
CAS No.:508233-74-7
- Ganoderic acid LM2
Catalog No.:BCN2442
CAS No.:508182-41-0
- Suchilactone
Catalog No.:BCN6752
CAS No.:50816-74-5
- Hastatoside
Catalog No.:BCN6898
CAS No.:50816-24-5
- Astrophylline
Catalog No.:BCN2151
CAS No.:5081-53-8
- Vasicinol
Catalog No.:BCN5812
CAS No.:5081-51-6
- Hellebrigenol
Catalog No.:BCN8238
CAS No.:508-79-2
- Convallatoxin
Catalog No.:BCC8155
CAS No.:508-75-8
- Rosenonolactone
Catalog No.:BCN5621
CAS No.:508-71-4
- Ouabagenin
Catalog No.:BCC8227
CAS No.:508-52-1
- N-acetylanonaine
Catalog No.:BCN2666
CAS No.:5894-74-6
- Friedelanol
Catalog No.:BCN5620
CAS No.:5085-72-3
- Tetramisole HCl
Catalog No.:BCC4735
CAS No.:5086-74-8
- 1,5,6-Trihydroxy-3-methoxyxanthone
Catalog No.:BCN8121
CAS No.:50868-52-5
- Neoliquiritin
Catalog No.:BCN6663
CAS No.:5088-75-5
- Liensinine diperchlorate
Catalog No.:BCN6336
CAS No.:5088-90-4
- 1,4-Bis(2-benzoxazolyl)naphthalene
Catalog No.:BCC8423
CAS No.:5089-22-5
- WY-14643 (Pirinixic Acid)
Catalog No.:BCC2265
CAS No.:50892-23-4
- 1-Acetyl-beta-carboline
Catalog No.:BCN3101
CAS No.:50892-83-6
- Gelsemine
Catalog No.:BCN5804
CAS No.:509-15-9
- Delsoline
Catalog No.:BCN5405
CAS No.:509-18-2
- Aconine
Catalog No.:BCN2394
CAS No.:509-20-6
- Napellonine
Catalog No.:BCN2536
CAS No.:509-24-0
Chromone glycosides and hepatoprotective constituents of Hypericum erectum.[Pubmed:19898802]
Arch Pharm Res. 2009 Oct;32(10):1393-7.
Two chromone glycosides, hyperimone A [7-(beta-D-glucopyranosyloxy)-5-hydroxy-2-(1-methylethyl)-4H-1-benzopyran-4-one (1)] and hyperimone B [7-(beta-D-glucopyranosyloxy)-5-hydroxy-3-methyl-4H-1-benzopyran-4-one (2)], together with six known compounds were isolated from the methanolic extract of the whole plant of Hypericum erectum. 1,3,5,6-Tetrahydroxyxanthone (5) and I3, II8-biapigenin (6) showed moderate hepatoprotective activity with EC(50) values of 160.2 +/- 0.6 microM and 217.7 +/- 1.3 microM, respectively, against tacrine-induced cytotoxicity in HepG2 cells.
Xanthones from roots, hairy roots and cell suspension cultures of selected Hypericum species and their antifungal activity against Candida albicans.[Pubmed:26194328]
Plant Cell Rep. 2015 Nov;34(11):1953-62.
KEY MESSAGE: Highest xanthone contents were found in Hypericum pulchrum and H. annulatum untransformed roots. The best anti- Candida activity was obtained for hairy roots extracts of H. tetrapterum clone 2 ATCC 15834. Extracts of root cultures, hairy roots and cell suspensions of selected Hypericum spp. were screened for the presence of xanthones and tested for their antifungal activity against Candida albicans strain ATCC 10231. At least one of the following xanthones, 5-methoxy-2-deprenylrheediaxanthone; 1,3,6,7-tetrahydroxyxanthone; 1,3,5,6-Tetrahydroxyxanthone; paxanthone; kielcorin or mangiferin was identified in methanolic extracts of the untransformed root cultures. The highest total xanthone content, with five xanthones, was found in untransformed H. pulchrum and H. annulatum root cultures. Hairy roots and the controls of H. tetrapterum contained 1,7-dihydroxyxanthone, while hairy root cultures and the corresponding controls of H. tomentosum contained toxyloxanthone B, 1,3,6,7- and 1,3,5,6-Tetrahydroxyxanthone. Two xanthones, cadensin G and paxanthone, were identified in cell suspension cultures of H. perforatum. Their content increased about two-fold following elicitation with salicylic acid. The anti-Candida activity of the obtained extracts ranged from MIC 64 to >256 microg ml(-1). Among the extracts of Hypericum untransformed roots, the best antifungal activity was obtained for extracts of H. annulatum grown under CD conditions. Extracts of hairy roots clones A4 and 7 ATCC15834 of H. tomentosum and clone 2 ATCC15834 of H. tetrapterum displayed inhibition of 90% of Candida growth with 256 mug ml(-1). Extracts from chitosan-elicitated cells did not show antifungal activity.
Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum.[Pubmed:1517742]
J Nat Prod. 1992 May;55(5):691-5.
Five tetrahydroxyxanthones, 3,4,6,7-tetrahydroxyxanthone [1], 1,3,5,6-Tetrahydroxyxanthone [2], 3,4,5,6-tetrahydroxyxanthone [3], 1,3,6,7-tetrahydroxyxanthone [4], and 2,3,6,7-tetrahydroxyxanthone [5] isolated from Tripterospermum lanceolatum inhibited angiotensin-I-converting-enzyme activity in a dose-dependent manner. The mode of inhibition of the tetrahydroxyxanthones (THXs) was found to be competitive inhibition. When the tetrahydroxy groups of THXs were blocked with acetyl groups, the angiotensin-I-converting-enzyme inhibitory activity was abolished, suggesting that the tetrahydroxy groups are indispensible for the inhibitory activity.
